Cochrane · systematic review · CD008864

Fibrinogen concentrate in bleeding patients

Wikkelsø, A, Lunde, J, Johansen, M, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Emergency and Critical CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Fibrinogen concentrate versus any comparator for patients with bleeding

Population: bleeding patients or at risk of severe bleeding
5 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality
Fibrinogen concentrate vs any comparator
RR 0.28 [0.03, 2.33]2 studies · 81 participantsVery low
Downgraded: risk of bias, imprecision
Incidence of allogenic blood transfusion Proportion of participants transfused with RBC, FFP, PLT and/or cryo
Fibrinogen concentrate vs any comparator
RR 0.47 [0.31, 0.72]5 studies · 207 participantsVery low
Downgraded: risk of bias, imprecision
Thrombotic episodes (arterial and venous graft occlusion, pulmonary embolus, deep venous thrombosis) Proportion with event
Fibrinogen concentrate vs any comparator
RR 1.03 [0.27, 3.97]3 studies · 124 participantsVery low
Downgraded: risk of bias, imprecision
Intensive care unit (ICU) stay Duration of stay (hours)
Fibrinogen concentrate vs any comparator
no estimate extracted3 studies · 112 participantsVery low
Downgraded: risk of bias, imprecision
Re‐operation due to persistent bleeding Events during admission
Fibrinogen concentrate vs any comparator
RR 0.68 [0.01, 36.71]2 studies · 124 participantsVery low
Downgraded: risk of bias, imprecision